########     ###    ##    ## ########  ######  
##     ##   ## ##   ###   ##    ##    ##    ## 
##     ##  ##   ##  ####  ##    ##    ##       
########  ##     ## ## ## ##    ##     ######  
##        ######### ##  ####    ##          ## 
##        ##     ## ##   ###    ##    ##    ## 
##        ##     ## ##    ##    ##     ######  

PETase ANnotation and Triage System

Nature's solution to a human-made health problem

One lineage, side by side

Every structure here was aligned onto IsPETase 6EQE when it was written, so these panels are already in register: rotating one rotates all of them, and the same view means the same orientation in every panel. The catalytic triad is drawn in yellow and substituted residues in pink, using the residues the geometry stage measured rather than positions inferred from an alignment.

The question this asks, which the catalogue cannot: do stabilising mutations keep clear of the catalytic machinery, or do some crowd it? Every substituted residue carries its side-chain distance to the nearest triad side chain, measured once from these coordinates. The wild types group asks a different question with the same machinery: those are natural enzymes from unrelated organisms that nobody has engineered, so what varies between them is what evolution did rather than what a protein engineer did.

Structures with no assigned lineage · 121–132 of 534

PAZy:121-nonPET

ESMFold prediction, pLDDT 89 · cleft 27.6 Å

PAZy:122-nonPET

AlphaFold model · cleft 24.3 Å

PAZy:13

ESMFold prediction, pLDDT 91 · cleft 21.2 Å

PAZy:132

ESMFold prediction, pLDDT 92

no triad measurable — this deposit is a catalytically inactivated form, with the nucleophilic serine replaced by alanine so the enzyme could be crystallised with substrate bound. The fold and every engineered substitution are right; the catalytic residue is simply not in the model, so the panel shows the whole molecule.

PAZy:133

ESMFold prediction, pLDDT 89

no triad measurable — this deposit is a catalytically inactivated form, with the nucleophilic serine replaced by alanine so the enzyme could be crystallised with substrate bound. The fold and every engineered substitution are right; the catalytic residue is simply not in the model, so the panel shows the whole molecule.

PAZy:134

ESMFold prediction, pLDDT 90 · cleft 21.1 Å

PAZy:135

ESMFold prediction, pLDDT 96 · cleft 22.0 Å

PAZy:136

ESMFold prediction, pLDDT 95 · cleft 21.9 Å

PAZy:137

ESMFold prediction, pLDDT 92

no triad measurable — this deposit is a catalytically inactivated form, with the nucleophilic serine replaced by alanine so the enzyme could be crystallised with substrate bound. The fold and every engineered substitution are right; the catalytic residue is simply not in the model, so the panel shows the whole molecule.

PAZy:138

ESMFold prediction, pLDDT 94

no triad measurable — this deposit is a catalytically inactivated form, with the nucleophilic serine replaced by alanine so the enzyme could be crystallised with substrate bound. The fold and every engineered substitution are right; the catalytic residue is simply not in the model, so the panel shows the whole molecule.

PAZy:139

ESMFold prediction, pLDDT 92

no triad measurable — this deposit is a catalytically inactivated form, with the nucleophilic serine replaced by alanine so the enzyme could be crystallised with substrate bound. The fold and every engineered substitution are right; the catalytic residue is simply not in the model, so the panel shows the whole molecule.

PAZy:14

ESMFold prediction, pLDDT 96 · cleft 24.6 Å

PAZy:132, PAZy:133, PAZy:137, PAZy:138, PAZy:139 have no measurable triad, and the reason is the deposit rather than the enzyme: these are inactivated crystallisation constructs with the catalytic serine mutated to alanine. Everything else about them is correct, including every engineered substitution, and the sequence held here is the active enzyme — only the coordinates are the knockout.

Distances are side chain to side chain, excluding backbone atoms. Measured any-atom to any-atom they came out at 1.31–1.35 Å for four variants, which is a peptide bond rather than a contact: those residues simply sit next to a triad residue in sequence. Where a substituted residue is adjacent in sequence it is marked, so a short distance that only reflects the fold's connectivity is visible as such. Panels built from predictions carry the loops that gate the cleft at lower confidence than the crystal structures beside them; a distance measured on one is weaker evidence than the same distance measured on the other.

Sequences one per panel above, in the same order

catalytic triad   substitution against the lineage wild type  · triad positions are labelled; hover any residue for its number. Click one to select it in its panel above, or click a residue in a panel to find it here.